Cargando…
Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancer
Linear accelerator-based radiotherapy has little effect on the majority of locally advanced neoplasms. Thus, the novel radiosensitizer Kochi Oxydol Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), which contains hydrogen peroxide and sodium hyaluronate, was developed. The effectiv...
Autores principales: | AOYAMA, NOBUTAKA, OGAWA, YASUHIRO, YASUOKA, MIKI, TAKAHASHI, MASAO, IWASA, HITOMI, MIYATAKE, KANA, YAMANISHI, TOMOAKI, HAMADA, NORIHIKO, TAMURA, TAIJI, NISHIOKA, AKIHITO, YAMAGAMI, TAKUJI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907062/ https://www.ncbi.nlm.nih.gov/pubmed/27347095 http://dx.doi.org/10.3892/ol.2016.4589 |
Ejemplares similares
-
Therapeutic results of a novel enzyme-targeting radiosensitization treatment, Kochi oxydol-radiation therapy for unresectable carcinomas II, in patients with stage I primary breast cancer
por: Aoyama, Nobutaka, et al.
Publicado: (2017) -
Therapeutic response to a novel enzyme-targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane
por: Aoyama, Nobutaka, et al.
Publicado: (2017) -
Actual practice of Kochi oxydol radiation therapy for unresectable carcinomas by intra-tumoral administration of hydrogen peroxide as a radiosensitizer
por: Obata, Shiro, et al.
Publicado: (2022) -
Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging
por: Yaogawa, Shin, et al.
Publicado: (2015) -
Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer
por: Ogawa, Yasuhiro, et al.
Publicado: (2015)